key: cord-0798785-xy0yn33b
authors: loganathan, Sundareswaran; Maheshkumar, Kuppusamy; Wankhar, Wankupar; Gurugubelli, Krishna Rao; Mahadevappa, Vidyashree Hodagatta; Lepcha, Lhakit; Choudhary, Arbind kumar
title: Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes
date: 2020-09-18
journal: Respir Physiol Neurobiol
DOI: 10.1016/j.resp.2020.103548
sha: b172881aefbfc5a571e74187f13760c223b12323
doc_id: 798785
cord_uid: xy0yn33b

BACKGROUND: Globally, the current medical emergency for novel coronavirus 2019 (COVID-19) leads to respiratory distress syndrome and death. PURPOSE: This review highlighted the effect of COVID-19 on systemic multiple organ failure syndromes. This review is intended to fill a gap in information about human physiological response to COVID-19 infections. This review may shed some light on other potential mechanisms and approaches in COVID -19 infections towards systemic multiorgan failure syndromes. FINDING: SARS-CoV-2 intervened mainly in the lung with progression to pneumonia and acute respiratory distress syndrome (ARDS) via the angiotensin-converting enzyme 2(ACE2) receptor. Depending on the viral load, infection spread through the ACE2 receptor further to various organs such as heart, liver, kidney, brain, endothelium, GIT, immune cell, and RBC (thromboembolism). This may be aggravated by cytokine storm with the extensive release of proinflammatory cytokines from the deregulating immune system. CONCLUSION: The widespread and vicious combinations of cytokines with organ crosstalk contribute to systemic hyper inflammation and ultimately lead to multiple organ dysfunction (Fig. 1). This comprehensive study comprises various manifestations of different organs in COVID-19 and may assist the clinicians and scientists pertaining to a broad approach to fight COVID 19.

Introduction that does not show symptoms is notable and needs attention. Alternatively, information from a presymptomatic individual can also occur before the onset of symptoms (i.e., during the time of incubation). Droplets (coughing or sneezing) and close contact play a central role in infection and human to human transmission. The probable asymptomatic incubation period of COVID-19 is varied from 2 to 14 days, and the mean incubation period is around five days (Lauer et al., 2020) . Hence, the symptoms may manifest in the individual from 2 days to 2 weeks after viral exposure. The SARS-CoV-2 virus has spike protein receptor binding and may use ACE2 as a functional receptor in stage 1 (Figure 2 ) for cellular entry ACE2 (Hoffmann et al., 2020) and leads to COVID-19 pathogenesis.

The SARS-CoV-2 genome consists of nucleotides nearly more than 30000 and encodes four structural proteins includes, Membrane protein, Spike protein, Envelope protein and nucleocapsid protein with several non-structural proteins. The capsid contains N-protein or nuclear capsid that binds to the single positive strand viral RNA that permits the virus to take over the human cells and convert them into viral factories. Additionally the N protein that coats the viral RNA genome plays a major role in transcription and replication. The spike protein on SARS-CoV-2 binds with ACE2 receptors on the surface of various cells mainly via the lungs causing the viral entry, where E protein's ion channel activity is found on the transmembrane region of the protein. E protein found to have a vital role in regulation and control of ion influx and efflux and thus the intracellular and extracellular environment. Hence, the ion conductivity triggered by E-protein via the manipulation of SARS-CoV-2genome may seem to be a novel route involved in pathogenesis of virus.

Ironically, ACE2, a gene mainly found in vascular endothelium in all structures such as type I and type II pneumocytes, smooth muscle cells in the pulmonary vasculature, bronchial epithelium, epithelial cells in the lungs, heart, intestine, blood vessels, testes and kidneys (Hamming et al., 2004; Imai, Dorigatti, Cori, Riley, & Ferguson, 2020) . SARS-CoV-2 (S protein) and ACE2 complex cleave S1 from S2 directly binds to the ACE2 RNA binding domain (RBD) (Figure 3 ). The ACE2 extracellular peptidase domain recognizes RBD via polar residues and facilitates viral entry through the direct plasma membrane and viral membrane fusion (Belouzard, Chu, & Whittaker, 2009) . Once entered into the host cells, Viral RNA genome translation occurs in the cytoplasm to form two structural proteins and polyproteins, that further assists the virus progeny assembly and eventually forms enveloped glycoproteins and genomic RNA within the protein machinery (Xiaowei Li, Geng, Peng, Meng, & Lu, 2020b; Perlman & Netland, 2009 ). In the cytoplasm, structured protein nucleocapsids were combined J o u r n a l P r e -p r o o f with accessory proteins, genomic RNA, and R protein in the endoplasmic reticulum, eventually release the virions through exocytosis from the infected cell (Shereen, Khan, Kazmi, Bashir, & Siddique, 2020) . The released infected viral particle readily binds with ACE2 receptors elsewhere (Z. Wu & McGoogan, 2020) and the process continues.

In response to viral and bacterial infections, the immune system develops both proinflammatory and anti-inflammatory cytokines. Following exposure to antigen-presenting cells (APCs) by SARS-CoV-2antigen, T cells release cytokines in various T cell subsets. They may further amplify the release of cytokine (cytokine storm) ( Figure 4 ) implies positive feedback between immune cells and cytokines (Kouhpayeh et al., 2020) . Alternatively, the genomic dsRNA virus may activate interferon regulatory factors and the NF-κB pathway, which releases enormous type I interferons and proinflammatory cytokines (Geng Li et al., 2020) .

The increased serum IL-6, C-reactive protein, and TNFα (P. . TNFα are likely to involve the proinflammatory condition in COVID-19 disease. The disease severity indicates the alteration in proinflammatory cytokines such as IL-7, IL-, IL-10, G-CSF, TNFα, IP-10, MIP-1A, MCP-1, in patients with COVID-19 .

Proinflammatory cytokines have been shown to encourage reactive oxygen species and the formation of free radicals that lead to oxidative stress and, ultimately, apoptosis and necrosis due to NAD+ and ATP exhaustion (Kouhpayeh et al., 2020) . Like neutrophils and macrophages, the activated phagocytes create vast quantities of reactive oxygen species and reactive nitrogen species to kill the invading agents during the inflammatory process. These intracellular sources of free radical generation may be subject to oxidative stress-induced DNA damage during viral infection (Kryston, Georgiev, Pissis, & Georgakilas, 2011) . In COVID-19 patients, oxidative stress and proinflammatory cytokines cause tissue damage mediated by inflammation. Therefore, oxidative stress and immune response deregulation result in cytokine storm, and pro-inflammation could lead to various organ dysfunctions in SARS-CoV-2 infection (C. Chen, Zhang, Ju, & He, 2020) (Table 2) .

The immune system is the multi-stage network for protecting the body against harmful bacteria, viruses, and other organisms. COVID-19's occurrence and development are mediated by viruses and the individual's immune system (Abdulamir & Hafidh, 2020) . The J o u r n a l P r e -p r o o f human self-immune system is the earliest tool to combat COVID-19. There has been little work on the relationship between SARS-CoV-2 and damage to immune cells (Table 1) . This review curiously focused on understanding the interaction between the host immune system and the COVID-19 outbreak based on accumulated data. The genetics of the immune system, e.g., HLA genes, can determine the individual infection, duration, severity, relapse, and reinfection (Xiaowei Li, Geng, Peng, Meng, & Lu, 2020a) . Also, the age factor is positively correlated with the SARS-CoV-2 viral load and clarifies the disease's severity in older patients . The aged population is prone, which could be the low immunity with higher viral load (Y. . Ironically, by resting at home (self-quarantine), the infected individuals or patients can cure themselves with acute COVID-19 infection (Cascella, Rajnik, Cuomo, Dulebohn, & Di Napoli, 2020) . It helps our immune cells to combat disease with COVID-19 and prevents transmission. The self-immune cells serve as a barrier, delay the virus's replication, and produce defensive antibodies and avoid further infections. In response to infection, the proliferation of T-cells may take a week to boost their condition. However, patients may rapidly worsen as the infected cell proliferates beyond the point where T-cells' efforts become helpless. Approximately 80% of COVID-19 patients experience a transition from mild to moderate with symptoms or no symptoms at all during this week. Yet, in the current situation to understand the immune responses is essential. Endothelium, one of the first line of the body defence system, plays a part in controlling the immune system through various receptors and cytosolic proteins (Takeuchi & Akira, 2010) . Endothelium secretes cytokines to regulate innate and adaptive immune responses, and at the site of action, it recruits immune cells (Marelli-Berg & Jarmin, 2004) . SARS-CoV-2 targets the endothelial host cell by binding its spike glycoprotein to the ACE2 receptor (Marelli-Berg & Jarmin, 2004) . SARS-CoV-2 targets the endothelial host cell by binding its spike glycoprotein to the ACE2 receptor (Lovren et al., 2008; Sardu et al., 2020) , which is highly expressed in lungs (Hamming et al., 2004) . Endothelial activation increases vascular permeability to plasma proteins, releases pro-inflammatory cytokines , tumour necrosis factor-(TNF-), chemokines, adhesion molecule (from activated leukocytes) and induces inflammation (Pober & Sessa, 2007) . The endothelial dysfunction stimulates a sequence of signalling molecules releasing nuclear factor-kB (NF-kB) to control both the innate and adaptive immune response (Oeckinghaus & Ghosh, 2009 ). If an innate immunity effort fails to abolish threat, it activates adaptive immune reactions and converts the acute inflammation into chronic inflammation (Seledtsov, Goncharov, & Seledtsova, 2015) .

Innate immune response: Innate immune responses to COVID-19, such as increased neutrophil, reduced lymphocyte, are related to infection and severity of disease and eventually J o u r n a l P r e -p r o o f contribute to the death of patients (F. Wu, Zhao, & Yu, 2020; P. Zhou et al., 2020) . Probably the leading cause of the life-threatening respiratory situation in COVID-19 patients is due to the secretions of granulocytes, and proinflammatory macrophages that damage cells and induce innate inflammation in the lungs (Z. . The lower frequency of recruitment of monocytes (CD16+CD14 +) in the COVID-19 patient's blood, shows the infection (Thevarajan et al., 2020) ,with no difference in frequency of NK (natural killer) cell (Thevarajan et al., 2020) . Effective innate immune responses to control the viral replication against viral infection depend on the Interferon-(IFN-) and Toll-like receptors 3 (TLR3) expressions (Kawai & Akira, 2006) . Endothelium chiefly expresses both IFN-and TLR3 (Tissari, Sirén, Meri, Julkunen, & Matikainen, 2005) and TLR9 against virus and bacteria (El Kebir, József, Pan, Wang, & Filep, 2009 ). Hence, highly efficient innate immune responses in young children could be a reasonable explanations for less severe SARS-CoV-2 infection (Kelvin & Halperin, 2020) . These facts indicate strongly that the innate immune response may act as a vital factor for the outcome of a disease.

developing autoimmunity or anti-inflammation (Cecere, Todd, & LeRoith, 2012) . CD4+ T cells specifically stimulate the production of virus-specific antibodies and the activation of Tdependent B cells (Xiaofeng Li et al., 2006) . CD8+ T cells are directly cytotoxic to the virally infected cells (Doherty et al., 1997) . However, the expression and survival of CD4+ T cells and CD8 + memory T cells depend on endothelium (Shiao, McNiff, & Pober, 2005) . Among SARS-CoV-2 -infected patients, the number of CD4 + T cells and CD8+T cells in the blood has been substantially decreased, showing evidence of excessive activation with elevated levels of HLA-DR (Z. . Moreover, increased concentration of proinflammatory substances in CD4+ T cells and cytotoxic granules in CD8+ T cells account for severe immune insults in this patient (Z. .

Multi-factorial immune responses such as increased antibody-secreting cells, helper T cells, activated CD4+ T and CD8+ T cells, IgM, and IgG antibodies were detected non-severe COVID-19 recovered patient's blood (Thevarajan et al., 2020) . Contrary to this, IgM & IgG antibodies were simultaneously increased on day 10th following the onset of symptoms in 23 patients with COVID-19 and this may clarify the neutralising activity of the antibodies with the surface spike receptor-binding domain of SARS-CoV-2 virus (Y. . The vulnerable SARS-CoV-2 nduces hardly any chronic symptoms after incubation and provokes protective immune responses. During the incubation period, the body develops multiple approaches to improve immune responses. The successful eradication of the SARS-CoV-2 consequences relies on the infected individual health status and antigen loci of major-J o u r n a l P r e -p r o o f histocompatibility complex (HLA) (X. Li et al., 2020b) . In case the infected personal general health and HLA haplotype (which elicits specific antiviral immunity) are unable to cope with the viral infections he/she may enter a severe stage and encounter the intense detrimental inflammatory response, especially in the lung (X. Li et al., 2020b) . Henceforth more detailed understanding of both the innate and adaptive immune responses to SARS-CoV-2 is now essential to understanding its pathogenesis.

Like the SARS coronavirus, COVID-19 patients usually develop upper respiratory tract illness (T. Wang et al., 2020) (Table 1 ). The ACE2 receptors markedly expressed in epithelial cells of the nasal cavity, type2 alveolar cells of lungs (Abassi, Skorecki, Heyman, Kinaneh, & Armaly, 2020), as well as heart, liver, kidney and gastrointestinal tract. In which lungs with the larger surface are more susceptible to COVID -19. Viral S protein on SARS-CoV-2 additionally requires various cofactors, especially TMPRSS2, found to be located in alveolar pneumocytes and responsible for SARS-CoV-2 entry and infection during interaction with host cell surfaces (Lukassen et al., 2020) . Notably, two proteases ADAM17 and TMPRSS2 decide the fate of ACE 2 influence on organs along with the SARS-CoV-2 towards multiorgan failure and viral pathogenesis (Heurich et al., 2014; Xiao, Sakagami, & Miwa, 2020) . The ventilatory ratio, a bedside index of lung dead space, and ventilation efficiency, is found to be increased in COVID-19 patients (X. Liu et al., 2020) . The major consequences and reason for life threatening are respiratory disorders at severe stages is also due to the hyperinflammation associated with the increase in proinflammatory cytokines and depressed innate immunity (Z. .

Patients with chronic obstructive pulmonary disease (COPD) are known to have increased expression of ACE2 receptors leads to severe lung diseases (Guoping Li et al., 2020) with chronic inflammation and pyroptosis (Tian et al., 2020) . The expression of ACE2 was not substantially different and does not indicate any difference in the susceptibility to COVID-19 infection among normal individuals and COPD asthma patients. However, persons with underlying lung disorders may be at higher risk for severe chronic airway disease or death (Guoping Li et al., 2020) . The exact mechanism and molecular interaction (including the various other proteins and cofactors) need to be focused during the interaction of SARS-CoV-2 with the lungs.

J o u r n a l P r e -p r o o f However, COVID-19 has reported significantly causing heart failure and death to persons with no signs of respiratory distress, regardless of harmful pre-cardiovascular disease (Madjid, Safavi-Naeini, Solomon, & Vardeny, 2020) . SARS-CoV-2 induces direct insult to myocardial cells and their dysfunction (Clerkin et al., 2020; Zheng, Ma, Zhang, & Xie, 2020) (Table 1 ). In Wuhan, China, 52 patients (27.8%) out of 187 patients had the history of myocardial injury with elevated Troponin T (T. Guo et al., 2020) and six patients (15%) out of 41 patients had cardiovascular illnesses . The level of plasma Troponin demonstrates a significant linear correlation for the levels of C-reactive protein and N-terminal pro-brain natriuretic peptide. In early and rapid diagnosis, cardiac Troponins can play an additional role in managing and categorizing the significant risk in cardiac patients and deciding on their emergency or surgical intervention care (Rajappa & Sharma, 2005) . In COVID-19 patients, cardiovascular markers such as Creatine kinase, Creatinine, Troponin I (cardiac), Brain Natriuretic Peptide, Lactate dehydrogenase, along with Alanine aminotransferase, Aspartate aminotransferase, and D-dimer concentration were markedly elevated (T. .

Myocardial injury in COVID-19 may also result from cardiac dysfunction and arrhythmias (T. Guo et al., 2020) . As compared to lungs, the heart is the second major organ reported to get highly affected by SARS-CoV-2 entry via SARS-CoV-2 spike protein with ACE2, widely expressed in the heart and lungs (Zou et al., 2020) . SARS-CoV-2 invades myocardial cells in the heart through ACE2, probably through pericytes resulting in increased macrophage infiltration, capillary endothelial cell dysfunction, and decreased ACE2 expression. The persistent increase in inflammatory cytokines following infection with COVID-19 may eventually lead to a reduction in coronary blood flow, oxygen supply, microthrombogenesis, and degradation of the coronary plaque (T. Guo et al., 2020) pays the way to myocardial injury and failure. Cytokine storms and hyper inflammation will further aggravate the above responses (Akhmerov & Marban, 2020).

The severity of the COVID -19 outbreak is attributed primarily to viral spike protein interaction with host cells through ACE2 receptors that are highly expressed in the heart and lungs (P. . Concerning viral load and subsequent incubation period (4-14 days), COVID-19 results in mild to severe symptoms associated with respiratory distress and heart failure (Lauer et al., 2020) . SARS-CoV-2 once targets with ACE2, might elevates the production of angiotensin II level through the action of NADPH oxidase activity (Rukavina Mikusic et al., 2014) ; and may lead to endothelial dysnfunction along with chronic myocardial hypoxia.

Cytokine storm and nitric oxide (NO: The effect of COVID-19 on the cardiovascular system could be further enhanced by an ACE2 deficiency correlating with reduced bioavailability of J o u r n a l P r e -p r o o f nitric oxide and an eNOS expression in the aorta (Rabelo et al., 2016) to control homeostasis of blood pressure and vascular injury. The elevated angiotensin II that stimulates the production of cGMP degrading phosphodiesterases results in decreased bioavailability of cGMP and cause vascular dysfunction and injury (Stegbauer et al., 2013) . However, the SARS-CoV-2 contribution and percentage towards myocardial injury via direct viral invasion or indirect systemic toxicity to multiple organs remains indistinct irrespective of the morbidity.

Therefore the harmful effects of COVID-19 on the heart will be mediated by SARS-CoV-2 viral load after its entry through the lungs (primary route). However, the COVID-19 manifestation on the myocardial damage and cardiovascular homeostasis either directly or indirectly remains elusive regardless of the morbidity.

Liver, a large metabolic organ that is continuously exposed to dietary antigens, viruses and has recently reported to have varying degrees of damage in patients with COVID-19 (Table 1) With an Increases in Alanine aminotransferase (ALT) or Aspartate aminotransferase (AST), followed by slightly elevated levels of bilirubin with or without mechanical ventilation (Gu, Han, & Wang, 2020; Zhang, Shi, & Wang, 2020; G. Zhang et al., 2020) . ). In COVID-19 patients, it is unclear whether the liver damage is caused by viral manifestations in liver cells or by the induced medication. ACE2 receptor in the target cell is the key binding site for SARS-CoV-2 virus, but the only medium expression of ACE2 in the liver is confirmed(M.-Y. Li, Li, Zhang, & Wang, 2020) ); however, bile duct cells (cholangiocytes) have highly enriched ACE2 receptors, which may support viral binding and derangements of liver function (Chai et al., 2020; Hoffmann et al., 2020) .

In contrast, immune responses to viral infection triggered by either immune interference or collateral damage to cytotoxic T cells and Kupffer cells in the liver may cause liver damage with no viral load (Bangash, Patel, & Parekh, 2020) . Non-specific inflammatory markers such as elevated neutrophil and neutrophil to lymphocyte counts (virus-induced cytokine storm), coagulation and fibrinolysis pathway activation in response to sustained inflammation, high levels of ferritin reflect the involvement of hepatic cells (Bai et al., 2020) (Table 1) . Also, a phenomenon called 'bystander hepatitis' that raises transaminases (AST and ALT) and J o u r n a l P r e -p r o o f circulatory cytokines may imply general immune stimulation or inflammation in systemic viral infections without compromising the function of the liver (Boettler et al., 2020) (Table 1) .

Uncertainly, COVID-19 infected patients with hepatotoxicity or liver injury may be due to antibiotics, antivirals and steroid medicines (Xu, Liu, Lu, Yang, & Zheng, 2020) .

We consistently indicate that liver injury in COVID-19 may be the direct insult to the liver or bile cells via receptors of ACE2. It is further aided by hyper inflammation, cytokine storm or bystander hepatitis and drug-induced damage. In COVID-19 diagnosis and management, patients already with comorbidities such as liver damage are recommended to treat with hepatoprotective medicines for better progress and outcome. We required further research to elucidate the effect of COVID-19 on the liver.

A recent study of COVID-19 on kidney dysfunction (Table 1) High levels of IL-6 in cytokine release syndrome may cause kidney damage. Possibly other various strategies towards kidney injury could be organ (Lung-kidney) crosstalk; inflammatory reactions and substances subsequently released lung damages could harm the kidney.

Alternatively, kidney epithelial cell injury also caused severe lung damage and other organs (Ronco & Reis, 2020) . COVID-19 patients with acute kidney injury had higher mortality risk (5.3 times) than those without acute kidney injury, and chronic disease patients had moderate mortality risk (1.5 times) (Z. Li et al., 2020b) . Therefore, monitoring the functions of the kidneys in COVID-19 patients regardless of chronic comorbid disease is equally important to reduce the risk of mortality and for improved outcomes. Patients need personalized medicine and J o u r n a l P r e -p r o o f differential management from the clinicians irrespective of the conditions; therefore, an indepth understanding of cardiopulmonary physiological interactions in COVID-19 patients is crucial for effective management.

We have précised concepts that link the pathogenesis of kidney dysfunction in COVID-19 infection. Renal tubular epithelial cells, organ crosstalk, and cytokine storm are the existing possible potential involvement in kidney damage and are strongly interrelated. It is hoped that baseline existing understanding will lead to earlier diagnosis, recognition, and treatment in the future to improve the outcomes of COVID-19 patients.

Reports of 'Neuro-COVID-19 units show a common occurrence of neurological symptoms in COVID-19 patients (Talan, 2020) (Table 1) . Symptoms of brain dysfunction such as headache, distressed consciousness develop in 40 % of patients with COVID-19 (Mao et al., 2020) .

SARS-CoV-2 in cerebrospinal fluid of infected patients suggests viral encephalitis (Cai et al., 2020) . In a few patients, even with neurologic symptoms, develop symptoms associated with COVID-19 (Mao et al., 2020) .

The olfactory dysfunction such as loss of taste or smell among COVID-19 patients suggests that viruses infect the olfactory neuron (Giacomelli et al., 2020; W.M, 2020.) Bain invasion through an ACE2 receptors : ACE2 is identified as the acting receptor for SARS-CoV-2, and present in multiple human organs, including the nervous system (Hamming et al., 2004) . The detection of ACE2 receptors over glial cells and other neurons, making them a potential target for SARS-CoV-2 (Baig, Khaleeq, Ali, & Syeda, 2020) and this can also disrupt the blood-brain barrier by disrupting the vascular system and reaching the CNS.

COVID-19 can potentially damage the capillary endothelium within the brain and contribute to elevated blood pressure. The risk of SARS-CoV-2 cerebral haemorrhage through an ACE2 receptor can result in abnormally high blood pressure and increase cerebral haemorrhage (Y. . Therefore, it is too recent to generate statistical evidence, and epidemiology of COVID-19 concerning CNS remains to be learned. Muscle relaxation has a positive effect on improving sleep quality and reducing anxiety (Polak et al., 1998) . The widespread deregulated cellular homeostasis of COVID-19 patients caused by pulmonary, renal, cardiac, and circulatory damage could complicate and manifest into various neurological complications yet to be learned.

The extrapulmonary manifestation of COVIDd-19 unfolds the symptoms of disease in digestive system. Includes nausea, vomiting, diarrhoea, abdominal pain and other nonspecific GI illness (Cipriano, Ruberti, & Giacalone, 2020; Gu et al., 2020; J o u r n a l P r e -p r o o f (Table 1 ). The finding of SARS-CoV-2 RNA in the stool sample, has gained much attention from clinicians and researchers towards GI inspection, symptoms and analysis (A. Tang et al., 2020; F. Xiao et al., 2020) (Table 1 ). In cancer patients COVID-19 was reported to have a higher risk (Liang et al., 2020) .

Laboratory report of COVID-19 patients with digestive symptoms showed higher liver enzymes, decreased monocytes, prolonged prothrombin time, and received additional antimicrobial management than patients with no digestive symptoms(Pan et al., 2020).

Interestingly, the presence of a virus among patients with confirmed SARS-CoV-2 is recorded in stool samples , from anal and rectal swabs (Holshue et al., 2020; Young et al., 2020) even after the clearance of virus in the respiratory tract (Cipriano et al., 2020) . It was also persistently positive on rectal swabs in 8 out of 10 paediatric patients, even after negative nasopharyngeal swabs tests (Y. . Tang et al., 2020) . Based on the above evidence, initial gastrointestinal symptoms in COVID-19 patient needs attention and notable. As it is highly involved in the community spreading and transmission, SARS-CoV-2 influence on GIT must be incorporated in early screening, detection, awareness, diagnosis, safety precautions, patient isolation, and early non-invasive diagnostic tool as much as respiratory symptoms are given importance. The extrapulmonary presentation of COVID-19 manifests the signs of illness within the digestive system, includes nausea, vomiting, diarrhoea, stomach pain and other nonspecific GI disorders (Cipriano, Ruberti, & Giacalone, 2020; Gu et al . , 2020; (Table 1) .

In COVID-19 cases, sepsis is one of the most expected outcomes (F. , suggesting RBC involvement in COVID-19 infection (Lippi & Plebani, 2020) . (Abrahams, 2020; N. Chen et al., 2020; Menk et al., 2018; (Table 1) . Bioinformatics analysis has found that SARS-CoV-2 glycoproteins such as orf1ab, orf10, and orf3a attacks 1beta chain of haemoglobin open reading frame 8 (ORF8) that binds to the porphyrin of haem and displaces iron (Wenzhong & Hualan, 2020) . In general, SARS-CoV-2 may not be considered to be the first known virus to alter porphyrin metabolism; hepatitis C virus (Hep C) and human immunodeficiency virus (HIV) infection also contribute to a non-acute form of porphyria (Wenzhong & Hualan, 2020) .

Porphyria is the disorder related with heme biosynthesis pathway and loss of autonomic control of breathing and autonomic neuropathy is a clinical feature of acute porphyria (Tracy & Dyck, 2014) .

Report on the relation between the ABO blood group and SARS-CoV-2 susceptibility to increased risk of COVID-19 infection among people with blood group A relative to other blood group (Zhao et al., 2020) . In patients affected by COVID-19, haemostatic abnormalities such as disseminated intravascular coagulation and pulmonary embolism have been reported Le Berre, Marteau, Emmerich, & Zins, 2020; Tang, Li, Wang, & Sun, 2020) . Most haemostatic abnormalities may occur due to increased D-dimer (Lippi & Favaloro, 2020) , thrombocytopenia (R. S. Wong et al., 2003) , prolonged prothrombin time (Le Berre et al., 2020) , thrombin time , elevated fibrin/fibrinogen degradation products and decreased activated partial thromboplastin time .

Hence, depending on the available reports, we have speculated that the primary pathogenic mechanism of COVID-19 does not only confide with lung. However, sepsis, acute porphyria, disseminated intravascular coagulation, and interaction of SARS-CoV-2 surface glycoprotein with 1-beta chain of haemoglobin (Wenzhong & Hualan, 2020) , is often the secondary complications observed in COVID-19 patients.

This review concluded ( Figure 5 ) that SARS-CoV-2 is intervened mainly through ACE2 receptor and other cofactors, mainly TMPRSS2 in the lung and further progress to pneumonia and ARDS. However, depending on viral load and regulated by the ACE2 receptor, an infection may further spread to other organs such as heart, liver, kidney, Brain, endothelium, GIT, immune cell, and RBC thromboembolism. This may follow with cytokine storm with an extensive discharge of proinflammatory cytokines from deregulating the immune system. This overall cytokine results in systemic inflammation and organ crosstalk resulting in multiorgan failure (Table 2 ). This finding may lead the clinician and scientist to the diverse approach to fight with COVID-19. More attention and studies are required to understand the involvement The newly developed genomic RNA, nucleocapsid, and enveloped glycoproteins assembled via endoplasmic reticulum and golgi complex to form viral particle buds. Finally, the vesicle that contains the virion fuses with the plasma membrane, resulting in viral release through exocytosis. The newly developed genomic RNA, nucleocapsid, and enveloped glycoproteins assembled via endoplasmic reticulum and golgi complex to form viral particle buds. Finally, the vesicle that contains the virion fuses with the plasma membrane, resulting in viral release through exocytosis. 

Case report To find the pathology of a COVID -19 patient died with acute respiratory syndrome (ARDS). (by obtaining biopsy samples at autopsy)

CD4 T cells as well as CD8 T cells were activated (as indicated by high HLA-DR) although they had significantly less count. There was also a high level of proinflammatory factor in CD4 T cells, and a high level of cytotoxic granules in CD8 T cells. 

To brief molecular improvement in immune pathology in COVID-19 based on infections with SARS-CoV and MERS-CoV.

The immune system influences of the person include human leukocyte antigen (HLA genes), when a person is infected with SARS-CoV-2 virus, prolongation and serious form of the disease, and reinfection.

(X. Li et al., 2020a) Editorial

To Observe immunological response of COVID-19-infected patient.

Multi-factorial immune responses with high levels of antibody-secreting cells (IgM and IgG antibodies) and CD4 T cells and CD8 T cells with more activation Up to recovery in the blood. 

Anti-inflammatory approaches against pro-inflammatory cytokines (IL-1 and IL-6) and COVID-19caused lung inflammation.

. IL-37 and IL-38 function as potential therapeutic cytokines which inhibit pro-inflammatory cytokine release.

. Research article Renin-angiotensin system inhibitors may be a safe alternative for COVID-19 pneumonia therapy

In COVID-19 patients with pneumonia, angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists inhibitors may reduce inflammatory response and mortality in the pulmonary system.

(M. Sun, Yang, Sun, & Su, 2020) Case study

Serial computed tomography finding in COVID-19 pneumonia Progress in both lungs with peripheral consolidations and ground-glass opacities. The lesions were removed after treatment leaving the fibrous lesions behind. (Wei et al., 2020) Research article The risk of severe increases with angiotensin-converting enzyme inhibitors and angiotensin blockers

Increases the receptors of ACE2, and acts as binding sites in the lungs for SARS-CoV-2 virions. (Diaz, 2020) Research article ACE-2 Expression in Small Airway Epithelia of smokers and COPD Patients: Implications for SARS-CoV-2 Expression of ACE-2 in Small Airway Epithelia of Smokers' and COPD Patients': Implications for COVID-19

In COPD patients and smokers the expression of ACE-2 in small epithelial cells of the airway has increased. ACE -2 is the SARS-CoV-2 entry receptor that contributes to serious infections. (Leung et al., 2020) Research article COVID-19 pathogenesis from a perspective of cell biology

The magnitude of COVID-19 can be understood by portion of the infected lung. Gas exchange section of the lung was involved in moderate infection, bringing airways and serious infection. (Mason , 2020) Review Neuroinvasive ability of COVID-19 in respiratory failure.

The Brain glial cells and neurons express ACE2, making them simple target for COVID-19.

(Baig et al., 2020)

Review Pathophysiology of COVID19 and its impact on cardiovascular system 

To detect positive patients with GI manifestations and faecaloral transmission in COVID-19.

The emphasis would be on the initial manifestations of COVID-19 digestive symptoms that would assist in early identification, diagnosis, early isolation, and rapid response. Research article To examine the prevalence and outcomes of Gastrointestinal symptoms in patients with cancer who are COVID-19 positive.

Digestive symptoms such as diarrhoea are usually seen in COVID-19 cancer patients and early increase in suspicion index should be considered in at-risk patients. (Liang et al., 2020) 

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Neurologic alterations due to respiratory virus infections

First case of 2019 novel coronavirus infection in children in Shanghai. Zhonghua er ke za zhi= Chinese journal of pediatrics

Features, evaluation and treatment coronavirus (COVID-19) Statpearls

Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? Viruses

Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection

Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies. Zhonghua shao shang za zhi= Zhonghua shaoshang zazhi= Chinese journal of burns

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

SARS-CoV-2: virus dynamics and host response. The Lancet Infectious Diseases

Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis

Coronavirus disease 2019 (COVID-19) and cardiovascular disease

Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies

SARS and MERS: recent insights into emerging coronaviruses

Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19

Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections

Bacterial DNA activates endothelial cells and promotes neutrophil adherence through TLR9 signaling

Commentary: What is the relationship between Covid-19 and cardiovascular disease?

Selfreported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study

A Tool to Early Predict Severe 2019-Novel Coronavirus Pneumonia (COVID-19): A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong

Perspective: cardiovascular disease and the Covid-19 pandemic

Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths

COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission

Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies

Potential pathogenesis of multiple organ injury in COVID-19

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status

Mitochondrial function in hypoxic ischemic injury and influence of aging

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

First case of 2019 novel coronavirus in the United States

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

COVID-19 and Diabetes: can DPP4 inhibition play a role?

Estimating the potential total number of novel Coronavirus cases in Wuhan City

Innate immune recognition of viral infection

COVID-19 in children: the link in the transmission chain. The Lancet Infectious Diseases

The Molecular Story of COVID-19; NAD+ Depletion Addresses All Questions in this Infection

Role of oxidative stress and DNA damage in human carcinogenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application

Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series

Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia. Diagnostic and Interventional Imaging

ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19

Coronavirus infections and immune responses

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues

Molecular immune pathogenesis and diagnosis of COVID-19

Molecular immune pathogenesis and diagnosis of COVID-19

A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis

Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management

The impact of COVID-19 on ischemic stroke: A case report

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Caution on Kidney Dysfunctions of COVID-19 Patients

Kidney Dysfunctions of COVID-19 Patients: A Multi-Centered, Retrospective, Observational Study

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia

D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis

Laboratory abnormalities in patients with COVID-2019 infection

Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19

Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19 Associated ARDS. American journal of respiratory and critical care medicine(ja)

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis

SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

COVID-19 and the cardiovascular system

Potential effects of coronaviruses on the cardiovascular system: a review

Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study

Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking? Immunology letters

Pathogenesis of COVID-19 from a cell biology perspective

Correspondence COVID-19: consider cytokine storm syndromes and

Nucleated red blood cells as predictors of mortality in patients with acute respiratory distress syndrome (ARDS): an observational study

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2

The case of Complement activation in COVID-19 multiorgan impact

The NF-κB family of transcription factors and its regulation

Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?

Coronavirus disease 2019 (COVID-19): situation report, 67. Organization, W. H. (2020b). Coronavirus disease 2019 (COVID-19): situation report, 73. Pan

Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study

Should Covid-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade

Coronaviruses post-SARS: update on replication and pathogenesis

Evolving functions of endothelial cells in inflammation

Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

Genetic deletion of ACE2 induces vascular dysfunction in C57BL/6 mice: role of nitric oxide imbalance and oxidative stress

Biomarkers of cardiac injury: an update

Advances in understanding the pathophysiology of lacunar stroke: a review

Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor

COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm?

Kidney involvement in COVID-19 and rationale for extracorporeal therapies

Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system

Is COVID-19 an Endothelial Disease? Clinical and Basic Evidence

Clinically feasible approaches to potentiating cancer cell-based immunotherapies

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma

COVID-19 infection: origin, transmission, and characteristics of human coronaviruses

COVID-19 infection: the perspectives on immune responses

Memory T cells and their costimulators in human allograft injury

Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

COVID-19 and liver disease

Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua jie he he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases

SARS-CoV-2 Entry Genes Are Most Highly Expressed in

Pattern recognition receptors and inflammation

Neurologists in Italy to Colleagues in US: Look for Poorly-Defined Neurologic Conditions in Patients with COVID-19

Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China. Emerging infectious diseases

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer

IFN-α enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases

Porphyria and its neurologic manifestations

Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan

Endothelial cell infection and endotheliitis in COVID-19

There's a new symptom of coronavirus, doctors say: Sudden loss of smell or taste

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

Relation between red cell distribution width and mortality in critically ill patients with acute respiratory distress syndrome

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan

Comorbidities and multi-organ injuries in the treatment of COVID-19

2019 novel coronavirus (COVID-19) pneumonia: serial computed tomography findings

COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

Covid-19 and the Digestive System

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease

A new coronavirus associated with human respiratory disease in China

Nervous system involvement after infection with COVID-19 and other coronaviruses

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults

Evidence for gastrointestinal infection of SARS-CoV-2

ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Viruses

Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Liver injury during highly pathogenic human coronavirus infections

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine

More Than Pneumonia, The Potential Occurrence of Multiple Organ Failure in 2019 Novel Coronavirus Infection. The Potential Occurrence of Multiple Organ Failure in

Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore

COVID-19 and multi-organ response

Liver injury in COVID-19: management and challenges

Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan

COVID-19: Melatonin as a potential adjuvant treatment

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Relationship between the ABO Blood Group and the COVID-19 Susceptibility. MedRxiv

COVID-19 and the cardiovascular system

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet

Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

We thankful to Mr. Dhilip Karthikeyan for assistance with illustration of figures that greatly improved the manuscript.

Nicotine may block entry of the virus via olfactory system or lung cells. Immune cells, neurons, lungs, cardiac tissue and blood vessels attributable to nicotine receptors (nAChRs). (Olds & Kabban i, 2020) 

Comments Assessed how the liver is affected using the available case studies in Beijing, China.Patients with severe COVID-19 tend to be experiencing elevated levels of liver dysfunction.(C. ReviewTo what extent chronic liver disorders should be considered as risk factors for COVID -19 infectionBecause of additional risk factors, Non-steroidal anti-inflammatory drugs should not be prescribed in patients with cirrhosis and portal hypertension (Boettle r et al., 2020) Guest Editorial COVID-19 and drug induced liver injury: a problem of plenty or a pettypoint SARS-CoV-2 infection can affect normal hepatic functions and has proven to be hepatotoxic in nature. (Boeck mans et al., 2020) Correspondence COVID-19 and the liver : little cause of concern Virally mediated cytotoxic T cells and activation of dysregulated inborn immune response can result in collateral damage to the liver. 

J o u r n a l P r e -p r o o f 43 Correspondence To study the acquired acute porphyria in critical covid-19 patients COVID-19 can alter porphyrin metabolism, decrease haemoglobin levels, increased total bilirubin levels and elevated serum ferritin levels make a chance of developing acute porphyria.(Abrah ams, 2020)Research paper To find risk factor in patient with COVID-19Sepsis, increased coagulation and elevated d-dimer were a common complication in older patients with COVID-19 infection.(F. Research paper Epidemiological and clinical characteristics of 2019 novel coronavirus pneumonia.In several patients the amount of lymphocytes and haemoglobin was below normal levels. However, increased C-reactive protein, alanine aminotransferase or aspartate aminotransferase is caused by viral infection due to drug hepatoxicity or liver dysregulation. (Menk et al., 2018) Research Among these, RDW was a strong prognostic predictor for extreme COVID-19, which suggested that turnover of RBC, could result in poor COVID-19 outcome.Research paper An observational research in patients with acute respiratory distress syndrome (ARDS) to see nucleated red blood cells as predictors of mortality.Nucleated red blood cells (NRBCs) are normally absent in healthy adult peripheral blood which cause elevated rates of pro-inflammatory cytokines, arterial hypoxemia and compensatory erythropoiesis. A total of 404 patients with essential ARDS were examined in which 75.5 % of the patient shows NRBCs in the blood. Research paper Relationship between Red Cell Distribution Width (RDW) and Mortality in Critically unwell patients with Acute Respiratory Distress Syndrome Inflammatory reactions and inflammatory cytokines may affect bone marrow function, repressed erythrocyte growth, resulting in high reticulocytes, and increased RDW. As such, RDW can be used as an effective prognostic marker in critically ill patients with ARDS (Wang, Gong, Ying, & Cheng, 2019) Research paper Investigating the interaction between the blood group ABO and vulnerability to COVID-19.Blood group A has a higher risk of infection with COVID-19, while Blood group O could be at lower risk due to the existence of anti-A antibodies that inhibit the attachment of SARS-CoV-2 protein-expressing cells to ACE2 (SARS-CoV-2 spike protein cell receptor). (Guillon et al., 2008; Zhao et al., 2020) Research paper To find blood clotting disorder in COVID-19 infected patientsHemostasis was deranged with a significant depletion of coagulation factors contributing to the risk of developing intravascular disseminated coagulation (DIC). Research Viral elements and inflammatory cells in the causes of endothelium apoptosis and pyroptosis (Varga et al., 2020) Article Proposing inhibition of the complement pathway for preventive, management and treatment of multi-organ damage in COVID-19Unhindered complement system activation caused by COVID-19 associated with multi-organ failure. (Noris, Benigni, & Remuzzi, 2020) Article COVID-19 pathogenesis and multiorgan damage AGTR2 may be a new target for treatment of COVD-19 patients (L. Guo et al., 2020) Article Assessing the relationship and potential function between COVID-19 and multiple organ failure other than pneumoniaThe direct viral impact via ACE2 may be injury to the other organs (Yang, Zhao, & Zhang, 2019) letter to editor Laboratory analysis of 25 fatal cases of COVID-19.Multiple organ failure syndromes is the leading cause of COVID-19 mortality most frequently observed in older male comorbidities patients. (Tu, Cao, Yu, Hu, & Liu, 2020)